A single dose of the Biontech/Pfizer BNT162b2 vaccine protected elderly residents from severe COVID‐19 during a SARS‐coronavirus‐2 outbreak in a senior citizen home in Germany

Background: A total of 62/66 (93.9%) residents in a senior citizen home in Bremen, Germany, received the first dose of the Biontech/Pfizer vaccine BNT162b2 on December 27th 2020. After routine severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) antigen tests showed positive results on Janua...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarzer, Rolf, Freys, Sabine D., Neuwinger, Nick, Beikert, Nina, Eberspächer, Bettina, Edelmann, Anke, Zuchowski, Marta, Slothouwer, Inga, Stein, Angela, Theil, Kathrin, Menzel, Peter, Hofmann, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589371/
https://www.ncbi.nlm.nih.gov/pubmed/34528766
http://dx.doi.org/10.1002/iid3.532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589371/
https://www.ncbi.nlm.nih.gov/pubmed/34528766
http://dx.doi.org/10.1002/iid3.532

Ejemplares similares